Skip to content

Insider · CIK 0001931328

Stephen Mark Cone

director

Files at BTMD (biote Corp.). First filing Mar 18, 2025, latest Mar 18, 2025.

Stephen Mark Cone files SEC Form 4 as director at BTMD (biote Corp.). Since Mar 18, 2025, Stephen Mark Cone has reported 1 open-market buy worth $148k and 0 open-market sells worth $0, the latest filed on Mar 18, 2025.

A track record needs three past buys with six months of prices behind them; Stephen Mark Cone has 0, so none is measured yet.

The newest scored trade: bought $148k of BTMD on Mar 17, 2025, filed Mar 18, 2025, scored 55 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$148k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BTMD: biote Corp.

BTMDOct 9, 2026 · close 1.15

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
BTMDbuy 5
biote Corp.
$148k
38,104 shares
+31%+30% from low-42% from high

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 12, 2026BTMD
biote Corp.
AGrant or award
Deferred Settlement RSUderivative
+31,481$0.00$069,822May 13, 2026
May 12, 2026BTMD
biote Corp.
AGrant or award
Stock Option (Right to Buy)derivative
+130,000$0.00$0130,000May 13, 2026
May 13, 2025BTMD
biote Corp.
AGrant or award
Deferred Settlement RSUderivative
+17,989$0.00$038,341May 14, 2025
May 13, 2025BTMD
biote Corp.
AGrant or award
Stock Option (Right to Buy)derivative
+104,547$0.00$0104,547May 14, 2025
Mar 17, 2025BTMD
biote Corp.
POpen-market purchase
Class A Common Stock
+38,104$3.88$148k160,829Mar 18, 2025

Questions about Stephen Mark Cone

Answered from the filings on this page, as of the latest one.

Is Stephen Mark Cone buying or selling?

Not in the last 12 months. Stephen Mark Cone's latest open-market trade on SEC Form 4 was bought $148k of BTMD on Mar 17, 2025.

How did Stephen Mark Cone's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Mark Cone has 0.

Where does Stephen Mark Cone file Form 4?

Stephen Mark Cone has filed Form 4 at BTMD (biote Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stephen Mark Cone: insider trades and track record | InsiderTell